Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DQA2 U allele: a genetic marker for relapse of Graves' disease.

Clinical endocrinology - 1 Feb 1990

Ratanachaiyavong S, Gunn C A, Bidwell E A, Darke C, Hall R, McGregor A M

Abstract excerpt

The association of HLA-DR3 with Graves' disease in Caucasoids is well established but its significance is unclear and its clinical value as a predictive parameter for relapse after a course of antithyroid drug therapy is controversial. We have further investigated the predictive value at the genomic level in 51 patients with Graves' disease who were treated with a 6-month course of carbimazole and followed up for...

Topics

Alleles
Blotting, Southern
Carbimazole
Female
Genes, MHC Class II
Genetic Markers
Graves Disease
HLA-DR3 Antigen
Humans
Male
Polymorphism, Restriction Fragment Length

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Recurrence

Source

Identifiers

PMID: 1971775
DOI: 10.1111/j.1365-2265.1990.tb00860.x

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 29 Aug 2026. Prepared record publication-1971775-2026-08-29.1. Manifest publication-graph-cohort-2026-08-29.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 29 Aug 2026.

Community interpretation

Discuss the evidence

Ask a question, add context or challenge an interpretation. Community activity is separate from scientific evidence strength.

0

discussions

0

replies

Citations encouraged

Claims remain attributable.

No discussion yet

Be the first to add a careful, cited interpretation.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DQA2 U allele: a genetic marker for relapse of Graves' disease.PMID 1971775Read ↗

Recurrence of Graves' Disease: What Genetics of HLA and PTPN22 Can Tell Us.Semantic proximity Read ↗

Genetic markers in diagnosis and prediction of relapse in Graves' disease.Semantic proximity Read ↗

Genotype and Phenotype Predictors of Relapse of Graves’ Disease after Antithyroid Drug WithdrawalSemantic proximity Read ↗

Association of the HLA-DRB1*0301 and HLA-DQA1*0501 alleles with Graves' disease in a population representing the gene contribution from several ethnic backgrounds.Semantic proximity Read ↗

HLA-DRB1*08, DRB1*03/DRB3*0101, and DRB3*0202 are susceptibility genes for Graves' disease in North American Caucasians, whereas DRB1*07 is protective.Semantic proximity Read ↗

Cytotoxic T lymphocyte-associated molecule-4 polymorphism and relapse of Graves' hyperthyroidism after antithyroid withdrawal.Semantic proximity Read ↗

HLA-DRB3 gene alleles in Caucasian patients with Graves' disease.Semantic proximity Read ↗

Cytotoxic T lymphocyte-associated molecule-4 gene polymorphism and hyperthyroid Graves' disease relapse after antithyroid drug withdrawal: a follow-up study.Semantic proximity Read ↗

Immunogenetic markers in patients with Graves' disease.Semantic proximity Read ↗

Implication of the HLA-DRB3 gene in Graves' disease: predominance of allele Dw24.Semantic proximity Read ↗

The human leukocyte antigen HLA DRB3*020/DQA1*0501 haplotype is associated with Graves' disease in African Americans.Semantic proximity Read ↗

Association of HLA-DQA1*0501 with Graves' disease in English Caucasian men and women.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.